StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
300970.SZ$29.00+2.62%
Fair $29.00+0.0%

300970.SZ

Jiangsu Chinagreen Biological Technology Group Co.,Ltd.

Consumer Defensive / Farm ProductsShenzhen

$29.00

+0.74 (+2.62%)

Fairly Valued+0.0%Fair Value $29.00Fund rank 25/100 · Data gapFallback financials|
SA 57/C
F-Score: 8/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 17%

FCF escenarios

weak_data · normalized FCF $-57.5M · quality 41.7/100

Data gap 25/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 13/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

57/100

C

Piotroski

8/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · 300970.SZLocal privado en este navegador · Jiangsu Chinagreen Biological Technology Group Co.,Ltd.
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$3.6B

P/E

15.4x

↓

EV/EBITDA

10.2x

↑

ROE

6.7%

↑

Gross Margin

16.1%

↓

Debt/Equity

0.35

↓
52-Week Range$29
$13$50

TradingView lightweight chart

300970.SZ price, volumen y niveles de valoración

Último $29.00Periodo -30.9%
Fair value: $29.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+19.8%

FCF CAGR

—

FCF margin

17.2%

FCF / Net income

2.01x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $1.29B · net income $110.3M · FCF $222.2M

2022-FY → 2025-FY

Gross margin

16.1%-0.2% pts

Operating margin

10.4%+0.7% pts

Net margin

8.5%-1.9% pts

FCF margin

17.2%+47.5% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$1.29B$1.29B$1.03B$996.2M$751.6M
Net Income$110.3M$110.3M$-47.6M$30.3M$78.3M
EBITDA$335.2M$335.2M$134.9M$168.7M$181.7M
EPS0.930.93-0.410.260.67
Gross Margin16.1%16.1%6.0%13.5%16.3%
Operating Margin10.4%10.4%-2.0%4.9%9.7%
Net Margin8.5%8.5%-4.6%3.0%10.4%
Balance Sheet
Debt/Equity0.350.350.380.220.19
Current Ratio4.134.13———
Cash Flow
Free Cash Flow$222.2M$222.2M$-130.4M$-57.5M$-228.1M
Returns
ROE6.7%6.7%-3.2%2.0%5.2%
Valuation
P/E15.4315.43—65.7326.07
EV/EBITDA10.2010.2011.1511.3710.45
P/B2.102.100.871.291.35
Growth & Yield
Revenue Growth25.2%25.2%3.6%32.5%—
EPS Growth326.8%326.8%-257.7%-61.2%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

40.4%

muy exigente

EPS terminal req.

$2.57

Spread vs growth

286.4%

5Y implied EPS CAGR

27.3%

muy exigente

EPS terminal req.

$3.11

Spread vs growth

299.5%

10Y implied EPS CAGR

18.4%

exigente

EPS terminal req.

$5.01

Spread vs growth

308.5%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +107.1%

Total return

+107.1%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.41 → 0.93

Residual

+107.1%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+107.1%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.